Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine

This study has been completed.
Sponsor:
Collaborator:
National Health Research Institutes, Taiwan
Information provided by:
Taipei Medical University Hospital
ClinicalTrials.gov Identifier:
NCT01401491
First received: May 19, 2011
Last updated: July 21, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)